(19)
(11) EP 2 457 908 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
05.04.2017 Bulletin 2017/14

(45) Mention of the grant of the patent:
23.11.2016 Bulletin 2016/47

(21) Application number: 12156039.5

(22) Date of filing: 15.10.2009
(51) International Patent Classification (IPC): 
C07D 309/10(2006.01)
C07H 13/04(2006.01)
C07D 333/12(2006.01)
 C07H 7/04(2006.01)
C07C 1/00(2006.01)
C07D 409/10(2006.01)

(54)

Process for the Preparation of Compounds useful as inhibitors of SGLT

Verfahren zur Herstellung von Verbindungen als Inhibitoren von SGLT

Procédé pour la préparation de composés utiles en tant qu'inhibiteurs de SGLT

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR
Designated Extension States:
AL BA RS

(30) Priority: 17.10.2008 US 106260 P
17.10.2008 US 106231 P
14.10.2009 US 578934

(43) Date of publication of application:
30.05.2012 Bulletin 2012/22

(62) Application number of the earlier application in accordance with Art. 76 EPC:
09736928.4 / 2346888

(73) Proprietors:
  • Janssen Pharmaceutica NV
    2340 Beerse (BE)
  • Mitsubishi Tanabe Pharma Corporation
    Osaka 541-8505 (JP)

(72) Inventors:
  • Filliers, Walter Ferdinand Maria
    B-2340 Beerse (BE)
  • Nieste, Patrick Hubert J.
    B-2340 Beerse (BE)
  • Hatsuda, Masanori
    Osaka, 541-8505 (JP)
  • Yoshinaga, Masahiko
    Osaka, 541-8505 (JP)
  • Yada, Mitsuhiro
    Osaka, 541-8505 (JP)
  • Teleha, Christopher
    Spring House, PA Pennsylvania 19477-0776 (US)
  • Broeckx, Rudy Laurent Maria
    B-2340 Beerse (BE)

(74) Representative: Warner, James Alexander 
Carpmaels & Ransford LLP One Southampton Row
London WC1B 5HA
London WC1B 5HA (GB)


(56) References cited: : 
WO-A1-2008/069327
 WO-A1-2009/035969
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).